“This Canadian approval follows an approval in Australia earlier this year and is the result of our aggressive strategy of registration and commercialization of our products in all major regulated markets. The successive registration of RESPIRAM in the USA, Australia and now Canada is a showcase of the high level of technical and regulatory expertise within our young company and our capability to bring products to all major countries”, said Dr Cuong Tu Ba, Founder and President of Modern Veterinary Therapeutics, LLC.